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Mitochondrial dysfunction and oxidative stress
are common features of Down syndrome (DS).
However, the underlyingmechanisms are not known.
We investigated the relationship between abnormal
energy metabolism and oxidative stress with tran-
scriptional and functional changes in DS cells.
Impaired mitochondrial activity correlated with
altered mitochondrial morphology. Increasing fusion
capacity prevented morphological but not functional
alterations in DS mitochondria. Sustained stimula-
tion restored mitochondrial functional parameters
but increased reactive oxygen species production
and cell damage, suggesting that reduced DS mito-
chondrial activity is an adaptive response for avoid-
ing injury and preserving basic cellular functions.
Network analysis of genes overexpressed in DS
cells demonstrated functional integration in path-
ways involved in energy metabolism and oxidative
stress. Thus, although preventing extensive oxida-
tive damage, mitochondrial downregulation may
contribute to increased susceptibility of individuals
with DS to clinical conditions in which altered energy
metabolism may play a role, such as Alzheimer’s
disease, diabetes, and some types of autistic spec-
trum disorders.
INTRODUCTION
Down Syndrome (DS), or trisomy 21, is characterized by
a complex phenotype that includes both developmental and
chronic health complications (Roizen and Patterson, 2003).
Altered mitochondrial activity and oxidative stress have long
been associated with DS (Arbuzova et al., 2002; Brooksbank
and Balazs, 1984). For example, DS cortical neurons exhibit
higher production of intracellular reactive oxygen species
(ROS) and lipid peroxidation, which compromise neuronal132 Cell Metabolism 17, 132–140, January 8, 2013 ª2013 Elsevier Insurvival (Busciglio and Yankner, 1995), and both DS neurons
and astrocytes display an abnormal pattern of protein process-
ing consistent with chronic energy deficits (Busciglio et al.,
2002). Altered mitochondrial activity has been reported in
DS fibroblasts (Valenti et al., 2011), and mitochondrial DNA
mutations were found in DS brain tissue (Coskun and Busciglio,
2012).
Microarray profiling of DS neural progenitor cells indicates an
association between altered chromosome 21 gene expression
and cellular injury mediated by oxidative stress (Esposito et al.,
2008). Similarly, DS amniotic fluid samples show altered activity
of oxidative-stress-associated genes early in pregnancy (Slonim
et al., 2009).
Oxidative stress has widely been associated with impaired
mitochondrial function andmorphology, leading to the disruption
of cable-like morphology and impaired ATP production (Knott
et al., 2008). Functional elongated mitochondria undergo
remodeling in response to energy requirements, cellular stress
or calcium oscillations (Chan, 2006), andmitochondrial fragmen-
tation is correlated with reduced ATP and increased ROS
production (Yu et al., 2006). With these considerations in mind,
we assessed the relationship between mitochondrial dysfunc-
tion, altered mitochondrial morphology, oxidative stress, and
transcriptional changes in DS cells. The results indicate that
reduced mitochondrial metabolism in DS is associated with an
adaptive response for preventing oxidative damage and
preserving cellular function.RESULTS
Altered Morphology and Increased Oxidative Stress
in DS Mitochondria
There is a close relationship between mitochondrial morphology
and functional state. Marked alterations in mitochondrial func-
tion previously identified in DS cells (Busciglio et al., 2002) led
us to examine mitochondrial morphology in normal (NL) and
DS astrocytes (Figure 1A). Mitochondria were classified accord-
ing to size in three groups: %3 mm, 3.1–15 mm, and R15.1 mm.
The mitochondrial network in DS cells is more fragmented, as
demonstrated by a significant increase in the number of shorterc.
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number of longer mitochondria (R15.1 mm) (Figure 1B). Electron
transport chain protein expression was similar in NL and DS cells
(Figure S1A available online), indicating that morphological and
functional changes were not related to changes in DS mitochon-
drial mass. We found shorter mitochondria in other DS primary
cell types, including fibroblasts (Figure S1B), neurons, and
pancreatic cells (see below), suggesting generalized perturba-
tions in DS mitochondrial function and morphology. Altered
mitochondrial morphology is associated with functional impair-
ment in DS cells, which exhibit reduced mitochondrial
membrane potential (MMP), oxidoreductase (ox/red) activity,
and ATP generation (Busciglio et al., 2002). Given the close asso-
ciation between mitochondrial morphology and function, we
investigated whether functional changes could be reverted by
manipulating DS mitochondrial morphology. Mitofusin 1 (mfn1),
a critical regulator of mitochondrial fusion, enhanced DS mito-
chondrial fusion (Figure 1C), increased the number of tubular
mitochondria, and reduced the number of puncta-like ones (Fig-
ure 1D). However, mfn1 expression had no effect on MMP
(Figures 1E and 1F). Similar results were obtained with mfn2
(data not shown).
Because correcting morphological alterations did not
enhance DS mitochondrial function, we investigated whether
DS cells actually possess the capacity to increase mitochondrial
activity after metabolic stimulation. To achieve a sustained
stimulation of mitochondria, we used 5 mM creatine for 7 days
(Andres et al., 2005). ATP level, ox/red activity, and MMP were
reduced in DS cells (Figures 1G–1I). Creatine did not affect mito-
chondrial activity in NL cells, but it markedly increased ox/red
activity, ATP levels, and MMP in DS cells (Figures 1G–1I), indi-
cating that upon stimulation, DS mitochondria possess the
capacity to increase energy metabolism. However, creatine
reduced DS cell survival, whereas it had no effect on the viability
of NL cultures (Figure 1J). One potential consequence of
enhanced mitochondrial activity is increased free-radical gener-
ation, which has been previously reported in DS (Busciglio and
Yankner, 1995). Under basal conditions, DS cells exhibited
3-fold higher levels of superoxide, expressed as the ratio of
MitoSOX Red over MitoTracker Green fluorescence area (NL:
4 ± 1%, DS: 16 ± 3%)(Figures 1K and 1L). Creatine nearly
doubled superoxide levels in both NL and DS mitochondria
(NL: 12 ± 5%, DS: 31 ± 9%) (Figure 1L). In addition, creatine
increased lipid peroxidation in DS cells (Figure 1M), consistent
with the observed decrease in cell viability (Figure 1J). Thus,
DS mitochondria are capable of sustaining increased activity.
However, this resulted in increased ROS generation, cellular
damage, and cell death.
GeneExpression inDSCells Is Associatedwith aPattern
of Chronic Oxidative Stress
We performed a broad-spectrum microarray analysis using
messenger RNA (mRNA) from three NL and five DS astrocyte
cultures. The microarray output was validated for several genes
(Figure S2A and Supplemental Experimental Procedures). A total
of 92 genes discriminated between NL and DS samples
(Figure 2A). Sixty genes were upregulated (>1.45-fold), 11 of
which are located in chromosome 21 (highlighted in red, Fig-
ure 2A). The other 32 genes were downregulated (<0.65-fold),Cellnone of which are localized in chromosome 21. Although chro-
mosome 21 genes were overrepresented among upregulated
genes (18.3%), the majority of them (81.7%) were located in
other chromosomes.
Ingenuity analysis generated a network illustrating the rela-
tionship between overexpressed genes (Figure S2B). Three
main pathways related to the upregulated genes were identi-
fied: (1) Nfr2-associated oxidative stress response, (2) oxida-
tive stress, and (3) mitochondrial dysfunction (Figure S2B). All
three pathways support the presence of chronic oxidative
stress in DS. To explore the relationship between gene expres-
sion and oxidative stress, we evaluated the expression of ‘‘DS
signature genes’’ in NL astrocytes subjected to mild oxidative
stress (50 mM H2O2 for 12 hr). In general, the changes in DS
signature genes in NL astrocytes plus H2O2 were smaller in
magnitude than the ones in DS cells. However, in most cases,
the expression in NL astrocytes plus H2O2 shifted in the same
direction as in DS cells, placing their profile somewhere
between the DS and NL profiles (Figure 2B) and further sug-
gesting that oxidative stress drives gene expression changes
in DS cells.
Altered Mitochondrial Morphology and Function in DS
Neurons
Given that cells with high energy demands are especially
susceptible tomitochondrial alterations, we assessedmitochon-
drial function in DS neurons. Mitochondria were classified
according to size as: puncta-like mitochondria (%300 nm in
diameter) (Figure 3A, small arrow); globular mitochondria (600–
1200 nm in diameter) (Figure 3A, arrowhead); and tubular mito-
chondria (R500 nm) (Figure 3A, big arrow). Mitochondria were
also shorter in DS neurons (Figure 3B). Similar results were ob-
tained by using MitoTracker Green and JC-1 (Figures S3A and
S3B). JC-1 labeling revealed a marked reduction in MMP, which
was accompanied by a decrease in ox/red activity and ATP
levels (Figure 3C and Figures S3D and S3E). JC-1 formed aggre-
gates in discrete domains of tubular and puncta-like mitochon-
dria, but never in globular mitochondria (Figure S3B), which
frequently colocalized with lisosomal markers (Figure S3C), sug-
gesting that the latter represent a subset of inactive or damaged
mitochondria. Interestingly, discrete energized regions in both
NL andDSmitochondria (Figures S3B and S3D) point to the exis-
tence of specific domains with different activities within indi-
vidual mitochondria in human neurons.
Impaired Mitochondrial Transport in DS Neurons
Because axonal transport is highly dependent on ATP and is
critical for synaptic activity and neuronal survival (Brady,
1991), we assessed anterograde mitochondrial transport in DS
neurons. DS mitochondria moved slower (350 ± 60 nm/s) than
NL mitochondria (1,100 ± 130 nm/s, Figures 3D and 3E).
Conversely, we observed a higher number of moving mitochon-
dria at any given time point in DS cells (38 ± 7% in DS cells; 20 ±
3% in NL cells; Figure 3F), which may be a compensatory
change. Both parameters were affected by creatine, which
also increased the number of energized mitochondria in DS
neurons (Figure S3E). Thus, reduced mitochondrial function
and ATP levels lead to impaired mitochondrial transport in DS
neurons.Metabolism 17, 132–140, January 8, 2013 ª2013 Elsevier Inc. 133
Figure 1. Mitochondrial Alterations in DS Astrocytes
(A) NL and DS astrocytes were stained withMitoTracker Green. Elongatedmitochondria predominate in NL astrocytes (NL, inset), whereas the number of puncta-
like and globular mitochondria was higher in DS astrocytes (DS, inset). The scale bar represents 10 mm.
(B) Quantification of mitochondrial shapes binned according to length and size in NL and DS astrocytes.*p < 0.05.
(C) A DS astrocyte (arrow) coexpressing pmfn1 and pCFPmit shows tubular mitochondria. In an adjacent, nontransfected DS cell (arrowhead), cytochrome C
immunofluorescence (IF) (green) illustrates shorter mitochondrial shapes. The scale bar represents 20 mm.
(legend continued on next page)
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Associated with Reduced Energy Metabolism
Pancreatic cells also require relatively high metabolic rates to
maintain secretory function. We examined mitochondrial
morphology, activity, and basal insulin secretion in NL and DS
islet cell clusters (ICCs) (Figure 4A). Both fetal pancreas and
ICCs expressed insulin and glucagon (Figure 4B, subpanels I
and II). Mitochondria in b cells were visualized with anti-cyto-
chrome C (Figure 4C). DS b cells exhibited fragmented mito-
chondria (DS, Figure 4D), as did NL b cells treated with 5 mM
FCCP for 1 hr (NL+FCCP, Figure 4D). Ox/red activity was
reduced in DS ICCs (73% ± 9% of NL ICC activity normalized
as 100%). Given that mitochondrial dysfunction is associated
with intracellular amyloid b accumulation in DS cells (Busciglio
et al., 2002), we assessed whether islet amyloid polypeptide
(IAPP, or amylin) accumulates in DS b cells. Insulin and IAPP
are coexpressed and localize to the same vesicles in b cells (Fig-
ure 4E), which were labeled with A11, a conformation-specific
antibody that recognizes IAPP oligomers (Kayed et al., 2007).
We found increased A11-positive puncta in DS b cells, 7.3 ±
2.6 puncta per cell in DS cells, and 1.7 ± 1.5 puncta per cell in
NL cells; n = 5 in both cases (Figure 4F, arrows). Thus, energy
deficits may result in abnormal intracellular accumulation of
IAPP in DS b cells.
NL b cells secreted 4-fold more insulin than DS b cells (Fig-
ure 4G). In contrast, DS b cells secreted 8-fold more proinsulin
than NL b cells (Figure 4H), indicating incomplete processing
and reduced insulin secretion. Neither creatine (5 mM) nor
antioxidant trolox (50 mM) alone had an effect on insulin or proin-
sulin secretion. However, when both compounds were added
together, we observed a slight increase in insulin (17 ± 5%)
and a reduction in proinsulin (24 ± 4%) secretion in DS ICCs
(Figures 4G and 4H). None of the treatments had a significant
effect on insulin or proinsulin levels in NL cells (data not shown).
Thus, mitochondrial downregulation may impair secretory func-
tion in DS b cells. The secretory deficits were partially corrected
by combined treatment with an energy buffer and an antioxidant,
underscoring the link between impaired cellular function, oxida-
tive stress, and mitochondrial alterations in DS.
DISCUSSION
Chronic oxidative stress and mitochondrial dysfunction are
conspicuous features of DS (Arbuzova et al., 2002; Slonim(D) Morphometric analysis shows a higher frequency of longer mitochondria and a
(E) A DS astrocyte cotransfected with pCFPmit and pmfn1 (subpanel I) shows lon
number of energized mitochondria did not change (JC-1 red). The scale bar repr
(F) JC-1 red/green ratio shows no differences in the frequency of energized mito
(G–I) Quantification of ATP (G), ox/red activity (H), andMMP (red/green JC-1 fluore
parameters of mitochondrial activity in DS astrocytes.*p < 0.01.
(J) Quantification of astrocyte viability (LDH). Note the reduction in viability in DS
(K) NL and DS astrocytes labeled with MitoTracker Green and MitoSOX. Simultan
live-cell mitochondria (mtgr, green). The scale bar represents 20 mm.
(L) Superoxide levels expressed as a MitoSOX/MitoTracker ratio (superoxide sig
further elevated by treatment with 5 mM creatine (NL + cre, DS + cre). *p < 0.05
(M) Quantification of lipid peroxidation. DPPP was used for monitoring lipid perox
treated with creatine (cre, 5 mM) exhibited a significant increase in lipid peroxida
Statistics: (B) and (D), Student’s t test; (G)–(J), (L), and (N), two-way ANOVA follo
(G–J, L, and M) Values are the mean ± SD; n = 8 independent experiments with
Cellet al., 2009). We found that mitochondrial morphology is
consistently altered in DS cells, which exhibit increased frag-
mentation. Mitofusin overexpression reverted the fragmented
phenotype. However, it did not improve MMP in DS cells.
Consequently, we investigated whether DS mitochondria actu-
ally possessed the capacity to increase ATP production after
metabolic stimulation. Creatine increased DS mitochondrial
activity and mitochondrial anterograde movement, but it
nearly doubled ROS levels, increased lipid peroxidation, and
reduced viability in DS cells. Thus, sustained stimulation resulted
in increased DS cell damage and death, suggesting that the
downregulation of DS mitochondria is part of an adaptive
response for avoiding excessive ROS generation and cellular
injury.
From a broader perspective, the relationship between mito-
chondrial morphology and function appears to be context
specific, depending on the cell’s state and the factors affecting
it. For example, in insulinoma cells, ATP-dependent hormone
secretion is not affected bymitochondrial fragmentation induced
with a dominant negative form of mfn1 but is significantly
reduced by hFis1 overexpression, which also generates a frag-
mented phenotype (Park et al., 2008). In the case of DS primary
cells, mitochondria are more fragmented, and both energy
production and some cellular functions are impaired. Thus, the
balance between mitochondrial morphology and function is
complex and is influenced by multiple factors.
We found 92 genes differentially expressed in DS cells. Inge-
nuity analysis generated a network of overexpressed genes
indicative of a transcriptional response to oxidative stress (Fig-
ure S2). These changes in gene expression may orchestrate
the cellular adaptations required for preserving homeostasis
in DS cells, including downregulation of energy metabolism.
This possibility is further supported by similar although less
pronounced changes in the expression of DS signature genes
in NL astrocytes under mild oxidative stress (Figure 2B). Under
basal culture conditions, which are nevertheless pro-oxidant,
and wherein DS energy metabolism is already impaired (Coskun
and Busciglio, 2012; Valenti et al., 2011), the adaptive response
would stabilize cell homeostasis at the expense of compro-
mising cellular functions dependent on particular energy require-
ments, e.g., insulin secretion in b cells or axonal transport in
neurons. At the organismal level, this adaptation may contribute
to the increased susceptibility of individuals with DS to patholo-
gies in which energy metabolism appears to be compromised,lower frequency of shorter ones in mfn1-expressing DS astrocytes. *p < 0.05.
ger mitochondria (JC-1 green) compared to a nontrasnfected astrocyte (II). The
esents 10 mm.
chondria in pmfn1-expressing astrocytes compared to nontransfected cells.
scence ratio, I). Treatment with 5mMcreatine (cre) markedly increased all three
astrocytes treated with creatine (5 mM). *p < 0.05.
eous staining allows the visualization of superoxide production (mtsox, red) in
nal/total mitochondrial signal). The superoxide level in DS mitochondria was
and **p < 0.01.
idation, which is expressed as arbitrary fluorescent units (AFU). DS astrocytes
tion (139% ± 11.2%). *p < 0.01.
wed by Tukey’s HSD test.
cultures derived from different NL and DS brain specimens.
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Figure 2. Gene Expression in DS Cells Is Associated with a Pattern of Chronic Oxidative Stress
Hierarchical cluster analysis and relative RNA expression in three NL and five DS astrocyte cultures are shown. Expression changes per gene with respect to the
average expression across all arrays are shown as a heat map. The fold-change color code is indicated at the bottom. Distance trees represent the relative
difference (branching distance) between genes (left) or between conditions (top).
(legend continued on next page)
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Figure 3. AlteredMitochondrialMorphology
and Function in DS Neurons
(A) Mitochondria in NL and DS neurons (21 days
in vitro) visualized with cytochrome C antibody.
Images were processed with an emboss filter.
Mitochondria were classified as tubular (large
arrow), puncta (small arrow), and globular (arrow-
head). The scale bar represents 5 mm.
(B) Quantification of mitochondrial morphotypes
expressed as a percentage of the total mito-
chondrial mass. Tubular mitochondria are
reduced whereas puncta- and globular-shaped
mitochondria are increased in DS cells. *p < 0.05.
(C) Reduced mitochondrial function in DS
neurons. MMP is expressed as a JC-1 red/green
ratio (JC-1). Ox/red activity (MTS) and ATP levels
(ATP) were assessed using commercial assays.
The results are expressed as a percentage of the
values found in NL cultures. DS cultures exhibit
significant reductions in all three parameters.
Values for each treatment were normalized to LDH
cellular levels. *p < 0.05.
(D) Mitochondrial transport in NL and DS neurons
(upper panel, differential interference contrast
[DIC] images) was recorded after live staining with
MitoTracker Green and processed with an
emboss filter. Images correspond to 0, 5, and 10 s
respectively in both NL and DS neurons (yellow
arrows). The traveled distance is specified in the
bottom panel. The scale bar represents 10 mm.
(E) Quantification of mitochondrial transport. DS mitochondria move slower than NL mitochondria. Creatine (5 mM; DS+cre) increased DS mitochondrial velocity
(cre: 5 mM creatine). *p < 0.05 and **p < 0.01.
(F) Quantification ofmobilemitochondria. NL and DS neurons were labeled withMitoTracker Green. Images acquired at 0 and 20 s time points were subtracted for
the generation of a ratio of stationary over moving mitochondria (see Supplemental Experimental Procedures). The number of moving mitochondria was higher in
DS neurons, and it was reduced to NL levels by treatment with 5 mM creatine (DS+cre). *p < 0.01.
Statistics: (B) and (C), Student’s t test; (E) and (F), one-way ANOVA followed by Tukey’s HSD test.
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autism (Capone et al., 2005; Esbensen, 2010; Lott and Head,
2005).
Recent studies have underscored the critical role of chronic
superoxide production leading to mitochondrial dysfunction,
telomere shortening, and replicative senescence in human cells
(Passos et al., 2007), further suggesting that the accelerated
senescence phenotype characteristic of DS cells (Pallardo´
et al., 2010) may also be a direct result of cumulative oxidative
damage and mitochondrial mutations (Coskun and Busciglio,
2012). Aneuploidies in general are detrimental to organismal
and cellular function, altering cell metabolism and decreasing
cell proliferation in yeast, mice, and humans, regardless of which
chromosome is affected (Williams et al., 2008). In fact, human
fibroblasts harboring different aneuploidies display similar
increases in sensitivity as well as in common cellular responses
to chronic oxidative stress (P.H. and J.B., unpublished data). In
this context, DS phenotypes at both the cellular and system
levels would arise from the interplay between specific changes
in chromosome 21 gene expression, operating on a background(A) A total of 92 genes were differentially expressed in DS cells. The DS fingerpri
cultures. A total of 60 genes were upregulated (red bracket), 12 of which are prese
bracket), none of which were located in chr 21.
(B) Relative RNA levels of the 92 genes in (A). The average expression of the thre
three NL cultures treated with H2O2 (see Supplemental Experimental Procedures
shifts in the same direction as in DS cells.
Cellof generalized metabolic perturbations and set off by the aneu-
ploid state.
In summary, DS cells exhibit chronic energy deficits that
appear to be part of an adaptive response to minimize oxidative
damage and preserve cellular homeostasis. Depending on
particular energy requirements, specific cellular functions will
be affected in different cell types. In the case of DS pancreatic
b cells, insulin secretion and proinsulin processing were sig-
nificantly improved only when antioxidant treatment and mito-
chondrial stimulation were applied together. Thus, combined
therapeutic strategies for preventing free-radical damage
and modulating energy metabolism may prove valuable for
managing some of the clinical manifestations commonly associ-
ated with DS.EXPERIMENTAL PROCEDURES
Cell Cultures
Primary human cortical neuronal and astrocyte cultures were established from
ten DS (17–20 weeks of gestational age) and ten age-matched control brainnt segregated NL from DS samples, each of which was derived from different
nt in chr 21 (highlighted in red). A total of 32 genes were downregulated (green
e NL and five DS cultures is shown in (A). NL+H2O2: average expression of the
). Note that the expression of DS ‘‘signature’’ genes in H2O2-treated astrocytes
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Figure 4. Altered Mitochondrial Morphology and Function in DS Pancreatic b Cells
(A) Fetal human pancreatic cells were grown as floating ICCs. NL and DS ICCs exhibited similar expansion rates. The scale bar represents 100 mm.
(B) b cells from the fetal pancreas (subpanel I) and ICCs (subpanel II) express insulin (ins, red) and glucagon (gluc, green). The scale bar represents 100 mm.
(C) Mitochondria visualized in an insulin-positive cell (ins, arrows) with anti-cytochorome C IF (cyt c). The scale bar represents 10 mm.
(D) Mitochondria were stained in b cells as described in (C). Note the increase in fragmented mitochondria in DS ICCs and in NL ICCs exposed to the electron
transport chain uncoupler FCCP (NL+ FCCP). The scale bar represents 10 mm.
(E) Colocalization of insulin and IAPP (amylin) in ICC b cells. The scale bar represents 10 mm.
(F) A11 imunoreactivity in DS ICCs. Sections of NL and DS ICCs were labeled with antibody A11, which recognizes IAPP oligomers. Note the increase in A11
staining in DS b cells (arrows). Nuclei were stained with DAPI. The scale bar represents 10 mm.
(G) Reduced basal insulin secretion in DS ICCs. Insulin secretion was measured in ICC conditioned medium. Note the small but significant increase in insulin
secretion in DS ICCs treated with 50 mM trolox and 5 mM creatine (DS cre tx). *p < 0.05 and **p < 0.01.
(H) Higher proinsulin secretion in DS ICCs. Note the marked increase in proinsulin levels in conditioned media of DS ICCs. Combined treatment with trolox and
creatine reduced proinsulin secretion in DS ICCs. *p < 0.05 and **p < 0.01.
(G and H) Statistics: one-way ANOVA followed by Tukey’s HSD test. Values are the mean ± SD; n = 5 independent experiments.
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Mitochondrial Adaptation in Down Syndromesamples (Busciglio et al., 2002). The protocol for tissue procurement complied
with federal and institutional guidelines for fetal research. Each experiment
was replicated with at least five different normal and DS cultures. For most
experiments, cortical neuronal and astrocyte cultures were used at 30–
35 days in vitro. Fetal pancreatic cultures were generated fromNL and DS fetal
pancreases as described (Beattie et al., 1997). Mitochondrial and endocrine
precursor cell function was analyzed at day 5 in culture.138 Cell Metabolism 17, 132–140, January 8, 2013 ª2013 Elsevier InImaging
Fluorescent images were generated with a Zeiss Axiovert 200 inverted micro-
scope, and image analysis was performed with AxioVision software custom-
ized macros. Mitochondria were classified by length intervals or according
to predetermined sizes as punctate, tubular, and globular and scored using
AxioVision. Mitochondrial transport and quantification of mobile mitochondria
were measured by time-lapse image analysis after a 20 min incubation withc.
Cell Metabolism
Mitochondrial Adaptation in Down Syndrome100 nM MitoTracker Green (detailed in Supplemental Experimental
Procedures).
Assessment of Mitochondrial Function
Mitochondrial ox/red wasmeasured using theMTS assay (Promega, Madison,
WI, USA). JC-1 (Invitrogen) was used for assessing MMP as a ratio between
the JC-1 red area (high-MMP mitochondria) and the JC-1 green area (total
mitochondria) after incubation with 200 nM JC-1 for 20min. A lactate dehydro-
genase (LDH) assay was used for assessing cell density (CytoTox 96, Prom-
ega). ATP levels were measured using chemiluminescence (CellTiter-Glo,
Promega). For all experiments, lipid peroxidation, ox/red, and ATP levels
were normalized to LDH cellular levels or total protein content. Both normali-
zation methods gave similar results.
Transfection
Cells were transfected with Lipofectamine (Invitrogen), and the plasmid of
interest was transfected in a ratio of 0.4 mg of DNA plus 1 ml of Lipofectamine
per 500 ml of medium. Full-length mitofusin 1 and mitofusin 2 plasmids (pmfn1
and pmfn2; Origene, Rockville, MD, USA) and mitochondrial-targeted cyan
fluorescent protein (pCFPmit) vector (Clontech, Palo Alto, CA, USA) were
confirmed via sequencing. Plasmid concentrations were selected after
dose-response curves were performed for finding the optimal conditions for
stimulating fusion but avoiding hyperfusion of the mitochondrial network. At
the indicated concentrations, none of the vectors caused hyperfusion, nor
did they affect cell viability.
Immunocytochemistry
Cell cultures and ICCs were fixed with 4% paraformaldehyde-0.12 M sucrose
in PBS and permeabilized with 0.1% Triton X-100 in PBS. Immunofluorescent
preparations were visualized using Alexa-conjugated secondary antibodies
(Invitrogen), as previously described (Helguera et al., 2005; Beattie et al.,
1997). The following primary antibodies were used: sheep anti-cytochrome
C (Abcam, Cambridge), rabbit anti-insulin (clone C27C9, Cell Signaling,
Danvers, MA, USA), mouse anti-IAP (Serotec, Raleigh, NC, USA), conforma-
tion-specific anti-oligomeric amyloid (A11, kindly provided by Dr. C. Glabe,
University of California, Irvine).
Gene Expression
Profiles were generated using total mRNA from NL astrocytes, NL astrocytes
treated with H2O2 (50 mM for 24 hr), and DS astrocytes and hybridized onto Hu-
manRef-8 v.2 Expression BeadChips (Illumina). See Supplemental Experi-
mental Procedures for technical details.
ELISA
Commercial kits for insulin (ALPCO Diagnostics, Windham, NH, USA) and
proinsulin (LIMCO Research, St. Charles, MO, USA) were used according to
manufacturer’s instructions. Conditioned media from NL and DS floating
ICCs were sampled after 5 days in culture.
Oxidative Stress
Mitochondrial superoxide was visualized using MitoSOX Red (Invitrogen),
which emits red fluorescence when oxidized by superoxide. Cells were treated
with MitoSOX Red (200 nM) for 10 min and colabeled with MitoTracker
Green (100 nM). The red/green ratio was used as an indicator of superoxide
production per mitochondrial mass. Lipid peroxidation was detected using
diphenyl-1-pyrenylphosphine (DPPP, Molecular Probes, Invitrogen). DPPP
fluorescence was quantified in a SpectraMax fluorometer (Molecular Devices).
Creatine Treatment
Cortical cultures were treated with 5mMcreatine for 7 days. ICCswere treated
with 5 mM creatine for 2 days. See Supplemental Experimental Procedures.
Statistical Procedures
Data were analyzed by one-way ANOVA followed by Tukey’s honestly signifi-
cant difference (HSD) test when the experiment included three or more groups
and by two-way ANOVA followed by Tukey’s HSD test for assays with two
independent variables. Student’s t test was performed for paired observa-
tions. A value of p < 0.05 was considered statistically significant. ResultsCellwere expressed as the mean ± SD. All experiments were repeated at least
three to five times, using cultures derived from different NL and DS specimens.
Each individual experiment was performed in at least triplicate samples.
ACCESSION NUMBERS
Raw microarray data sets have been deposited in the NCBI Gene Expression
Omnibus (GEO) database under accession number GSE42772.
SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.cmet.2012.12.005.
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